Delcath Systems, Inc. Share Price Nasdaq
Equities
US24661P1049
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
01:50pm | HC Wainwright Adjusts Price Target on Delcath Systems to $22 From $20, Maintains Buy Rating | MT |
14/05 | Transcript : Delcath Systems, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Sales 2024 * | 2.67Cr 222.54Cr | Sales 2025 * | 6.98Cr 581.78Cr | Capitalization | 20Cr 1.64TCr |
---|---|---|---|---|---|
Net income 2024 * | -3.7Cr -308.57Cr | Net income 2025 * | -60L -50Cr | EV / Sales 2024 * | 7.36 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
-4.94
x | P/E ratio 2025 * |
-707
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.27% |
Latest transcript on Delcath Systems, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Gerard Michel
CEO | Chief Executive Officer | 60 | 01/20/01 |
Sandra Pennell
DFI | Director of Finance/CFO | - | 07/23/07 |
David Hoffman
CMP | Compliance Officer | - | 25/22/25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Stoll
BRD | Director/Board Member | 81 | 05/08/05 |
Gerard Michel
CEO | Chief Executive Officer | 60 | 01/20/01 |
Director/Board Member | 58 | 14/20/14 |
1st Jan change | Capi. | |
---|---|---|
-9.51% | 2.11TCr | |
+8.42% | 1.88TCr | |
+11.12% | 1.41TCr | |
+10.07% | 1.02TCr | |
-12.55% | 222.07Cr | |
+8.56% | 178.28Cr | |
+34.04% | 164.19Cr | |
+24.42% | 65Cr | |
0.00% | 39Cr |